-
Optimizing Dose and Leveraging Biomarkers for Enhanced Patient Safety in Immunotherapy Trials HubXchange Immunotherapies brought together almost 40 senior-level scientists and exec ...
-
Tumor cells have developed sophisticated mechanisms to evade the immune system, posing significant challenges to effective cancer treatment. Recent research has elucidated several ...
-
The University of Birmingham has launched Europe's first clinical trial investigating the use of an mRNA-based vaccine to combat pancreatic cancer, a significant advance in persona ...
-
In the rapidly evolving landscape of precision medicine, one of the greatest challenges lies in predicting individual patient responses to therapeutic agents. Drug efficacy and tox ...
-
The use of machine learning (ML) in the analysis of vast biological datasets is revolutionizing our approach to drug discovery, personalized medicine, and therapeutic outcome predi ...
-
Farcast Biosciences, a research solutions company and developer of the TruTumor platform—a large fragment, near-native tumor preservation and histo-culture platform enabling precis ...
-
Nanotechnology, once confined to the realm of theoretical research, is now revolutionizing biomedical science, particularly in cancer diagnostics and therapy. Nanorobots, designed ...
-
BNT116, developed by BioNTech, is an advanced mRNA-based therapeutic vaccine designed specifically to target non-small cell lung cancer (NSCLC). This vaccine falls within the broad ...
-
In the dynamic and rapidly evolving field of antibody therapeutics, the ability to identify targets with optimal therapeutic windows is a critical determinant of clinical success. ...